Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Epigenetics. 2013 Feb;8(2):220-8. doi: 10.4161/epi.23605. Epub 2013 Jan 16.
Deregulated expression of microRNAs (miRNAs) is common and biologically relevant in cervical carcinogenesis and appears only partly related to chromosomal changes. We recently identified 32 miRNAs showing decreased expression in high-grade cervical intraepithelial neoplasia (CIN) and carcinomas not associated with a chromosomal loss, 6 of which were located within a CpG island. This study aimed to investigate to what extent these miRNAs are subject to DNA methylation-mediated transcriptional repression in cervical carcinogenesis. Methylation-specific PCR (MSP) analysis on a cell line panel representing different stages of human papillomavirus (HPV) induced transformation revealed an increase in methylation of hsa-miR-149, -203 and -375 with progression to malignancy, whereas expression of these miRNAs was restored upon treatment with a demethylating agent. All three miRNAs showed significantly increased levels of methylation in cervical carcinomas, whereas methylation levels of hsa-miR-203 and -375 were also significantly increased in high-grade CIN. A pilot analysis showed that increased hsa-miR-203 methylation was also detectable in HPV-positive cervical scrapes of women with high-grade CIN compared with controls. Similar to recent findings on hsa-miR-375, ectopic expression of hsa-miR-203 in cervical cancer cells decreased both the proliferation rate and anchorage independent growth. We found evidence for methylation-mediated transcriptional repression of hsa-miR-149, -203 and -375 in cervical cancer. Methylation of the latter two was already apparent in precancerous lesions and represent functionally relevant events in HPV-mediated transformation. Increased hsa-miR-203 methylation was detectable in scrapes of women with high-grade CIN, indicating that methylated miRNAs may provide putative markers to assess the presence of (pre)cancerous lesions.
miRNAs 的表达失调在宫颈癌的发生中很常见且具有生物学相关性,并且似乎仅部分与染色体变化有关。我们最近发现 32 种 miRNA 在高级别宫颈上皮内瘤变(CIN)和与染色体缺失无关的癌中表达下调,其中 6 种位于 CpG 岛上。本研究旨在探讨这些 miRNA 在宫颈癌发生中受 DNA 甲基化介导的转录抑制的程度。在代表 HPV 诱导转化不同阶段的细胞系面板上进行甲基化特异性 PCR(MSP)分析显示,随着恶性转化的进展,hsa-miR-149、-203 和 -375 的甲基化增加,而用去甲基化剂处理后这些 miRNA 的表达得到恢复。这三种 miRNA 在宫颈癌中均显示出明显增加的甲基化水平,而 hsa-miR-203 和 -375 的甲基化水平在高级别 CIN 中也明显增加。一项初步分析表明,与对照组相比,在患有高级别 CIN 的 HPV 阳性妇女的宫颈刮片中也可检测到 hsa-miR-203 甲基化水平升高。与 hsa-miR-375 的最新发现类似,在宫颈癌细胞中异位表达 hsa-miR-203 可降低细胞增殖率和锚定非依赖性生长。我们发现 hsa-miR-149、-203 和 -375 在宫颈癌中存在甲基化介导的转录抑制。后两者的甲基化在癌前病变中已经很明显,代表 HPV 介导的转化中具有功能相关性的事件。在患有高级别 CIN 的妇女的刮片中可检测到 hsa-miR-203 甲基化增加,表明甲基化 miRNA 可能提供潜在的标记物来评估(癌前)病变的存在。